Omada shares pop 42% in Nasdaq debut after health tech company's IPO

Shares of Omada Health surged by over 40% during their debut on the Nasdaq, after pricing their initial public offering (IPO) at $19 per share. The stock opened at $23 and quickly climbed to more than $27, reflecting a strong market reception. In a press release issued late Thursday, Omada announced the sale of 7.9 million shares in the offering, raising approximately $150 million. The IPO pricing fell within the anticipated range, placing the company's valuation at just over $1 billion, potentially higher when fully diluted. Founded in 2012, Omada operates under the ticker symbol "OMDA" and specializes in virtual care programs aimed at assisting patients with chronic conditions such as prediabetes, diabetes, and hypertension. The company was co-founded by Sean Duffy, who currently serves as CEO, alongside Andrew DiMichele and Adrian James, both of whom have since pursued other ventures. This marks the second digital health IPO within a few weeks, following a lengthy period of stagnation in the sector. Earlier this year, Hinge Health, a digital physical therapy startup, made its debut on the New York Stock Exchange. Hinge's shares are currently valued at $38.50 after being initially offered at $32. The tech IPO landscape appears to be revitalizing, exemplified by Circle Internet's recent 168% surge in their NYSE debut. Other companies like eToro and Chime Financial have also entered the market recently, with Chime set to launch next week. Duffy remarked on the timing of the IPO, stating, "Today is the right moment for us. We like the scale of the model, we like the scale of the business, and we felt pull from the capital markets." According to its prospectus, Omada's revenue in the first quarter rose by 57% to $55 million, up from $35.1 million the previous year. The company anticipates a 38% increase in revenue for 2024, projecting $169.8 million compared to $122.8 million in the prior year. Additionally, Omada's net loss decreased to $9.4 million in the first quarter, a significant drop from $19 million a year earlier. Major investors in Omada include U.S. Venture Partners, Andreessen Horowitz, and Fidelity's FMR LLC, each holding between 9% and 10% of the company's stock.